Plain-English translation of NCT07484607 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study wants to better understand what happens in your lungs during a cystic fibrosis flare-up (called an exacerbation) โ specifically, how inflammation and infection change during treatment. Researchers will collect blood, sputum, and urine samples, plus lung function tests, during both stable periods and when you're admitted to hospital for treatment of a flare-up. The goal is to learn how standard antibiotic treatment works and what signs predict who will have more flare-ups.
Cystic fibrosis flare-ups are serious and can damage your lungs over time, but doctors don't fully understand what happens inside your airways during these episodes or how to predict who will have the most trouble. Better understanding could lead to better treatments and ways to prevent future flare-ups.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You'll visit a participating CF centre for a baseline assessment when you're feeling stable โ this includes lung function tests, blood draws, and sputum samples. If you don't have a flare-up in the next two years, you'll return for a repeat visit after 12 months. If you're admitted to hospital for treatment of a flare-up, you'll have additional assessments at specific time points during your hospital stay (before antibiotics start, and then at days 3, 7, and 10 of treatment) to track how your lungs and inflammation respond.
AI-generated summary from trial data ยท Jun 8, 2026 ยท Not medical advice
United Kingdom